Understanding Placebo Mechanisms to Reduce Attrition in Psychiatric Trials
Placebo responses in psychiatric trials are clinically significant and variable.1 When placebo response is large, the assay sensitivity of a clinical trial can be impacted, meaning that it can potentially result in a failure to detect efficacy for an active treatment.2 The constituent effects that combine to produce a placebo response are multiple and include both specific placebo mechanisms (eg, expectation effects) and nonspecific effects (eg, regression to the mean).1,3 An additional factor that might impact estimates of both treatment and placebo response is missing data.
Authors
- Samuele Cortese
- Marco Solmi (ORCID: https://orcid.org/0000-0003-4877-7233)
- Nathan T. M. Huneke (ORCID: https://orcid.org/0000-0001-5981-6707)
Institutions
- National Health Service (GB)
- University of Ottawa (CA)
- Ottawa Hospital (CA)
- Isle of Wight NHS Trust (GB)
- University of Southampton (GB)
- University of Bari Aldo Moro (IT)
- New York University (US)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1001/jamapsychiatry.2025.0303
- Citations
- 3
- Primary Topic
- Pain Management and Placebo Effect
- Type
- article
- Field-Weighted Citation Impact
- 4.29